Larvol Delta - AltruBio-to-Present-Abstract-on-Checkpoint-Regulator-Neihulizumab-as-a-Novel-Therapy-for-Immunological-Diseases-at-the-BampT-CellMediated-Autoimmune-Disease-Drug-Development-Virtual-Summit

neihulizumab (AbGn-168H) - AltruBio

https://www.globenewswire.com/news-release/2021/10/06/2309493/0/en/AltruBio-to-Present-Abstract-on-Checkpoint-Regulator-Neihulizumab-as-a-Novel-Therapy-for-Immunological-Diseases-at-the-B-T-Cell-Mediated-Autoimmune-Disease-Drug-Development-Virtual.html

Oct 6, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next